ArticleFrontiers in sports and active living2026
Prevalence, burden and risk markers of health problems in HYROX athletes: a 12-week prospective cohort study.
Article in Frontiers in sports and active living, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: HYROX is a rapidly growing fitness competition combining eight 1-km running intervals with eight functional fitness stations. This study investigated the epidemiology and markers of health problems in HYROX athletes. Method: Eighty-nine HYROX athletes (56 female) completed the 'Oslo Sports Trauma Research Center Questionnaire on Health Problems' (OSTRC-H2) weekly for 12 weeks, alongside exposure reporting and a baseline questionnaire. In an exploratory analysis, potential risk markers (age, sex, previous injury and HYROX experience) for cumulative injury severity were examined using negative binomial regression with an exposure offset. Results: The mean weekly response rate was 62%. The pooled weekly prevalence of any health problem was 30% (95% CI 24% to 37%), with a substantial-problem prevalence of 18% (95% CI 13%-24%). Injury incidence was 14.4 (95% CI 11.1-18.4) per 1,000 h, with a time-loss incidence of 6.4 (95% CI 4.3-9.2); injuries attributed to HYROX training accounted for two thirds of episodes (9.6 per 1,000 h). Overuse injuries accounted for 73% of injuries. The knee was the most frequently injured region (22% of episodes) and, with the lower leg, carried the greatest burden; the elbow ranked third for burden on the basis of four episodes, two of them persistent, while shoulder injuries were near-absent. Previous injury carried the largest rate ratio for cumulative severity, at 2.60 (95% CI 1.00-6.75), an interval also compatible with no association. Conclusions: Health problems were common in HYROX athletes and dominated by overuse injuries. The burden was led by the lower limb, consistent with the sport's running load, with a possible elbow contribution from two persistent injuries and a near-absence of shoulder problems, a combination that may distinguish the profile from other extreme conditioning programme training but which rests on few cases. Only half of problems involved time-loss, so missed-training-day surveillance understates the burden. Previous injury is a candidate risk marker requiring confirmation in larger cohorts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.